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Phellinus linteus, a natural growing mushroom, has been known to exhibit anti-tumor, anti-inﬂammatory, anti-allergic and anti-
oxidant eﬀects. Aiming to exploit the neuroprotective eﬀects of P. linteus,w ee v a l u a t e di t se ﬀects on infarct volume reduction
in a rat model of focal cerebral ischemia. Male Sprague-Dawley rats were subjected to right middle cerebral artery occlusion.
Filtrate of P. linteus broth culture (various doses), fractionated ﬁltrate (based on molecular weight) or control medium was
administered intraperitoneally to rats before or after ischemia induction. Rats were killed at 24h after the stroke surgery.
Cortical and caudoputaminal infarct volumes were determined separately using an image analysis program following staining
with 2,3,5-triphenyltetrazolium chloride. Signiﬁcant cortical infarct volume reductions were found in the pre-treatment groups
(30 and 60minutes before onset of cerebral ischemia)compared with the control group, showing dose dependence. Posttreatment
(30minutes after ischemic onset) also signiﬁcantly reduced cortical infarct volume. Furthermore, the higher molecular weight
(≥12000) fraction of the culture ﬁltrate was more eﬀective compared with the lower molecular weight fraction. The present
ﬁndings suggest that P. linteus may be a new promising approach for the treatment of focal cerebral ischemia, with the additional
beneﬁt of a wide therapeutic time window since signiﬁcant infarct volume reduction is obtained by administration even after
the ischemic event. Our ﬁnding that the higher molecular weight fraction of the P. linteus culture ﬁltrate demonstrated more
prominent eﬀect may provide a clue to identify the neuroprotective substances and mechanisms.
1.Introduction
Phellinus linteus (Berk. Et Curt.) Teng has long been used as
traditional oriental medicine, and is known as “song gen” in
Chinese and “meshimakobu” in Japanese. Investigations of
the pharmacologic eﬀects of P. linteus were started in Japan
about40 years ago, and this mushroom showed the strongest
anti-tumor eﬀects compared to other mushrooms [1]. P.
linteus is now attracting attention for its anti-inﬂammatory,
anti-allergic, anti-tumor and anti-oxidant eﬀects [2–4].
Tea catechins are known to act as antioxidants by scav-
enging free radicals and chelating metal ions [5, 6]. Like tea
catechins, caﬀeic acid also possesses a catechol moiety in its
structure. Caﬀeic acid may exhibit antioxidant eﬀect by the
same mechanism as that of tea catechins. Caﬀeic acid was
extracted from the culture of P. linteus mycelia [7]. It would
appear that the antioxidant eﬀect of P. linteus may be due to
caﬀeic acid.
Cerebral infarction is caused by death of brain tissues
mainlyduetothromboembolicocclusionofacerebralartery.
The patient suﬀered from sequelae including hemiparesis,
sensory disturbance, aphasia, memory disturbance and vis-
ual disturbance. The severity of the sequelae depends on
not only the area of the ischemic focus but also the area
of penumbra. Some reports indicated that free radicals
generated during ischemia play a prominent role in neural
damage [8, 9]. In this context, studies have shown that
eliminating active oxygen has strong cerebroprotective eﬀect
on brain ischemia [10].
The eﬀectsofP. linteus on central and peripheral nervous
systems have not been reported. In the present study, we pre-
or post-treated middle cerebral artery occlusion rat models2 Evidence-Based Complementary and Alternative Medicine
with the ﬁltrate of P. linteus broth culture to estimate its
cerebroprotective eﬀect. The study was designed to elucidate
the eﬀective dose, the therapeutic time window and the
eﬀective fraction of the ﬁltrate.
2.Materialsand Methods
2.1. Surgical Procedures of Middle Cerebral Artery (MCA)
Occlusion Models. The experimental protocol used in this
study was approved by the Ethics Committees for Animal
Experimentation at Tokyo Women’s Medical University.
Male Sprague-Dawley rats (8-week old and weighing 270–
330g) were maintained on a regulated 12-h light:dark cycle
and allowed free access to water and food. Rats were
anesthetized with 1mLkg−1 phenobarbital sodium by intra-
peritoneal injection. Body temperature was maintained at
37±0.5◦C using a feedback-regulated heating pad during
the procedure. The right femoral artery was cannulated for
continuousmonitoringofarterialbloodpressureandarterial
blood gas levels (PaO2,P a C O 2, pH and base excess), hemat-
ocrit and glucose level. Arterial blood gas and glucose levels
were analyzed before the ischemic surgery and immediately
after the ischemia.
A modiﬁed, permanent MCA occlusion model by clip-
ping the proximal right MCA was adopted in this study [11].
In brief, a 10-mm linear skin incision and a muscle incision
were made between the lateral corner of the right eye and
the external auditoty oriﬁce. The temporal bone between the
orbital ﬁssure and the foramen ovale, especially the temporal
base, was drilled and removed. The dura was dissected and
opened to approach the right MCA. The zygomatic arch,
orbital contents and the facial nerve were preserved during
the whole procedures as reported previously by our group
[11–15]. A pial dissection along the MCA was performed to
provide space for the clip. The proximal side of MCA (just
proximal to the olfactory nerve) was occluded by applying
theclip[11]. The MCAwas electrocoagulated fromthe point
ofclippingtojustproximaltotheleveloftheinferiorcerebral
vein with a bipolar diathermy and transected using a surgical
microscope [11–15].
2.2. Experimental Protocols. Phellinus linteus strain PL-08
was used in the present study. The strain is maintained at
IBI Co., Ltd, Yamanashi, Japan. The mycelia of strain PL-08
were cultured for 45 days in a broth medium containing 4%
glucose, 0.3% yeast extract, 0.3% polypeptone, 0.05% potas-
sium dihydrogen phosphate and 0.05% disodium hydrogen
phosphate in distilled water, adjusted to pH 5.5. For culture,
a 5-L fermenter was used and incubated at 25◦Ci nad a r k
chamber.Sterilizedairwaspassedintothefermenterthrough
a ﬁlterwith pore size 0.22μm (Millez-FG50; Millipore, USA)
at a ﬂow rate of 1Lmin−1. The 45-day broth culture was
ﬁltered and divided into mycelia and culture ﬁltrate. The
culture ﬁltrate was used as the test substance in the present
study.
Four percent and 20% culture ﬁltrates were prepared
by diluting the neat ﬁltrate in distilled water. Appropriate
volumes of the two culture ﬁltrates were administered to
obtain various doses. As a preliminary screening for the
molecules responsible for the neuroprotective eﬀect, we
fractionated the 20% culture ﬁltrate into two fractions at
ac u t o ﬀ molecular weight (MW) of 12000. For the same
purpose, we also prepared a glycoprotein extract from the
2 0 %c u l t u r eﬁ l t r a t e .T h e r e f o r e ,at o t a lo ft h r e ef r a c t i o n so f
P. linteus culture ﬁltrate were tested in the present study and
designated Groups 7 (MW<12000), 8 (MW≥12000) and
9( g l y c o p r o t e i n ) .T h eP. linteus culture ﬁltrate was prepared
(20%) and three volumes of ethanol were added. The
resulting suspension was lyophilized.Foradministration, the
powder was dissolved in phosphate buﬀer (20mgmL−1).
The rats were assigned randomly to 12 experimental
groups (nine PL-08 treatment groups and three control
groups). Before or after experimental induction of focal
cerebral ischemia, the culture ﬁltrate (treatment groups) or
medium(controlgroups)wasadministered intraperitoneally
to the rats according to the protocol as follows: Group 1:
1.5mLof20%cultureﬁltrateat60minbeforeischemiconset
(n = 5), Group 2: 2.5mL of 20% culture ﬁltrate at 60min
beforeischemiconset(n = 5),Group 3:2.5mLof4%culture
ﬁltrate at 30min before ischemic onset (n = 5), Group 4:
1.5mLof20%cultureﬁltrateat30minbeforeischemiconset
(n = 7), Group 5: 2.5mL of 20% culture ﬁltrate at 30min
before ischemic onset (n = 7), Group 6: 1.5mL of 20%
culture ﬁltrate at 30min after ischemic onset (n = 7), Group
7: 2.5mL of fraction with MW<12000 at 30min before
ischemiconset(n = 6),Group8:2.5mLoffractionwithMW
≥ 12000 at 30min before ischemic onset (n = 6), Group
9: 2.5mL of glycoprotein extract at 30min before ischemic
onset (n = 8), Control 1: control for Group 3; 2.5mL of 4%
medium at 30min before ischemic onset (n = 5), Control
2: control for Groups 1, 4 and 6; 1.5mL of 20% medium at
60min before (for Group 1), 30min before (for Group 4)
or 30min after (for Group 6) ischemic onset (n = 11), and
Control 3: control for Groups 2, 5, 7, 8 and 9; 2.5mL of 20%
mediumat60minbefore (forGroup 2)or30min before(for
Groups5,7,8and9)ischemic onset(n = 15).Weconsidered
the three control groups necessary because the diﬀerences in
glucose and other compositions in the inocula may aﬀect the
infarct volume.
Twenty four hours after the stroke surgery, the animals
werekilledwithanoverdoseofintraperitonealphenobarbital
sodium and decapitated.
2.3. Evaluation of Infarct Volume. Brain samples were
obtained 24h after the surgery. Sevencoronal sections 2-mm
thickness were cut and immediately stained with 2% 2,3,5-
triphenyltetrazolium chloride (TTC) [16, 17]. The cerebral
infarction area in the brain slice was measured with an image
analysis program (Beta4.0.2ofScion Image).To compensate
for the eﬀect of brain edema, the infarct volume was
determined using an indirect method: infarct area= (area of
theintactcontralateralhemisphere)−(areaoftheintactipsi-
lateral hemisphere) [18]. The infarct volume was expressed
as a percentage of the intact contralateral hemispheric
volume. Infarct volume of the cortex and caudate putamen
was measured separately. Infarct volume in the cortex wasEvidence-Based Complementary and Alternative Medicine 3
(a)
(b)
Figure 1: Representative 2,3,5-triphenyltetrazolium chloride-stained bra i ns e c t i o n sf o l l o w i n gr i g h tp r o x i m a lM C Ao c c l u s i o ni nt h ec o n t r o l
group ((a); Control 3) and the Phellinus linteus culture ﬁltrate-treated group ((b); Group 5). Infarct volumes in the P. linteus-treated group
are smaller than those in control group. Coronal sections are obtained from locations +4.5, +2.5, +0.5 and −1.5mm relative to the bregma
in each group.
measured using slices 2 through 5 and infarct volume in the
caudate putamen was measured using slices 3 and 4.
2.4. Statistical Analysis. The researchers who performed
intraperitoneal injection, ischemic surgery and infarct vol-
umemeasurement were blindedtowhich groupsthe animals
were assigned until all data had been collected. Values
presented, in this study, are expressed as mean ± SD. One-
way analysis of variance (ANOVA) followed by post hoc
Tukey-Kramer test was used to determine the statistical
signiﬁcance of diﬀerences in physiological variables and
infarct volumes among all the groups. A P-value <.05 was
considered statistically signiﬁcant.
3.Results
3.1. Physiological Parameters. There were no signiﬁcant
diﬀerences among all groups in body temperature; arterial
blood pressure; arterial blood gas levels including PaO2,
PaCO2, pH and base excess; hematocrit; and blood glucose.
3.2. Infarction Volume
3.2.1. Overall Analysis. As described previously [12–16]
infarcts produced by occlusion of the proximal MCA involve
the dorsolateral cerebral cortex and underlying subcortical
structures in the ipsilateral hemisphere (Figure 1). Specif-
ically, infarcts involve regions of the cortex controlling
sensorimotor functions of the contralateral limbs, as well as
the caudate putamen (Figure 1).
In the analysis of Group 3 (2.5mL of 4% culture ﬁltrate
at 30min before ischemic onset) compared with Control 1,
no diﬀerences in infarct volume in the cortex (60.6±9.2%
versus 60.1±4.4%) and the caudate putamen (40.7±10.6%
versus 42.5±13.8%) were observed.
In the analysis of Groups 1, 4 and 6 compared with
Control 2, signiﬁcant diﬀerence in cortical infarct volume
was detected (F = 12.04, P<. 0001; 66.2±6.6%,




































on infarct volume in cortex. Infarct volumes (%) are presented
as mean ± SD, and are calculated by the “indirect method”.
C1–3 are control groups and G1–9 are P. linteus-treated groups.
See Methods for explanations of the 12 groups. ∗a: Statistically
signiﬁcant diﬀerences, C3 versus G2, G5, G7, G8 and G9. ∗b:
Statistically signiﬁcant diﬀerences, C2 versus G6.
6 and Control 2, resp.) (Figure 2). Furthermore, signiﬁcant
diﬀerences in cortical infarct volume were observed when
comparing Group 6 (1.5mL of 20% culture ﬁltrate at 30min
after ischemic onset) with Control 2 and Group 4 (the same
dose at 30min before ischemic onset) (one-way ANOVA
followed by post hoc Tukey-Kramer test) (Figures 2 and 3).
These results indicated that post-ischemic treatment with
culture ﬁltrate was eﬀective in reducing infarct volume
compared with control, and the eﬀect was also observed
when compared with pre-ischemic treatment. There were
no signiﬁcant diﬀerences in infarct volume in the caudate
putamen (49.0±17.5%, 42.3±12.0%, 44.6±15.2% and
































Figure 3: Eﬀect of administration of Phellinus linteus culture
ﬁltrate on infarct volume in cortex: comparing pre-ischemic treat-
ment (30min before ischemic onset) and post-ischemic treatment
(30min after ischemic onset). Infarct volumes (%) are presented
as mean ± SD, and are calculated by the “indirect method”. G4
(low dose) and G5 (high dose) are pre-treatment groups and G6
(low dose) is post-treatment group. Cortical infarct volume is
signiﬁcantly reduced in the group administered the ﬁltrate 30min
after ischemic onset (G6) compared with the group administered
the same dose 30min before ischemic onset (G4). ∗Statistically
signiﬁcantdiﬀerences.
In the analysis of Groups 2, 5, 7, 8 and 9 compared
with Control 3, signiﬁcant diﬀerence in cortical infarct
volume was detected (F = 6.75, P = .0001; 44.4±11.6%,
46.2±7.9%, 49.3±8.3%, 46.2±8.0%, 43.3±12.3% and
62.8±7.3%, in Groups 2, 5, 7, 8, 9 and Control 3, resp.)
(Figure 2). Furthermore, signiﬁcant diﬀerences in cortical
i n f a r c tv o l u m ew e r eo b s e r v e dw h e nc o m p a r i n gt h ea l lﬁ v e
groups versus Control 3 (one-way ANOVA followed by post
hoc Tukey-Kramer test) (Figure 2). There were no signiﬁ-
cant diﬀerences in infarct volume in the caudate putamen
(40.2±15.5%, 42.5±12.6%, 38.5±13.4%, 36.9±14.8%,
36.1±9.1% and 49.6±9.1% in Groups 2, 5, 7, 8, 9 and
C o n t r o l3 ,r e s p . ) .
Because there were no signiﬁcant diﬀerences in cortical
infarct size among the three control groups (Control 1, 2
and 3), the treatment groups could be compared directly as
described below.
3.2.2. Pre-Ischemic Treatment. According to the statistical
analyses mentioned above, pre-ischemic treatment with the
culture ﬁltrate at 60min (Groups 1 and 2) or 30min
(Groups 3, 4 and 5) before cerebral ischemia reduced cortical
infarction signiﬁcantly at the highest doses (Group 2 and
Group 5) (Figures 2 and 4). There were no signiﬁcant


































































on infarct volume in cortex: dose dependence in pre-ischemic
treatment at 60min (a) and at 30min (b) before ischemic onset.
Infarct volumes(%) are presented asmean ± SD,andare calculated
by the “indirect method”. G1:lowdose,G2: highdose,G3:lowdose,
G4: medium dose, G5: high dose. For each treatment schedule, the
highest dose (G2 and G5) shows signiﬁcantly greater reduction of
infarct volume. ∗Statistically signiﬁcant diﬀerences.
before ischemia using the same doses (Group 1 versus Group
4 and Group 2 versus Group 5).
3.2.3. Post-Ischemic Treatment. In Group 6, culture ﬁltrate
was administrated at 30min after ischemic onset. This post-
ischemic treatment was signiﬁcantly eﬀective in reducing
the cortical infarct volume compared with control, and the
eﬀect was also signiﬁcantly great when compared with pre-
ischemic treatment using the same dose (Group 4), while
there was no signiﬁcant diﬀerence between Group 4 and
control (Figures 2 and 3). Post-ischemic treatment at 30min
after ischemic onset using a lower dose showed similar eﬀect
as pre-ischemic treatment using a higher dose (Group 5
versus Group 6) (Figure 3).
3.2.4. Dose Dependence. To examine dose dependence, we
compared the cortical infarct volumes at each pre-treatment
time. In the 60-min pre-treatment groups, there was a
signiﬁcant diﬀerence between Group 1 (lower dose) and
Group2(higherdose)(F = 11.043,P = .0127)(Figure 4(a)).
In the 30-min pre-treatment groups, there was a signiﬁcant
diﬀerence among the three groups in cortical infarct volume
(Groups 3, 4 and 5; F = 5.858, P = .0123) (Figure 4(b)).
The diﬀerences were signiﬁcant when comparing Group 5
(highest dose) with Group 3 (lowest dose) and with GroupEvidence-Based Complementary and Alternative Medicine 5
4 (medium dose) (one-way ANOVA followed by post hoc
Tukey-Kramer test) (Figure 4(b)).
These results showed dose dependence in treatment with
of P. linteus culture ﬁltrate for cortical cerebral infarction.
3.2.5. Fractionation of Culture Filtrate Based on Molecular
Weight. When we fractionated the 20% culture ﬁltrate into
two fractions according to a MW cutoﬀ of 12000, 92.4%
of the components were in the fraction with MW<12000
while only 7.6% were in the fraction with MW≥12000.
Both fractions were similarly eﬀective in reducing cortical
infarct volume (49.3±8.3% in Group 7 (MW<12000) and
46.2±8.0% in Group 8 (MW≥12000)) (Figure 2)a n d
there was no statistical diﬀerence between the two groups.
Since the higher MW fraction gave signiﬁcant eﬀect despite
containing a small portion of the components (7.6%), this
result suggests a possibility that the higher MW fraction may
contain a high proportion of active ingredients responsible
for the infarct volume reduction eﬀect.
3.2.6. Glycoprotein Extract. The glycoprotein extract of the
culture ﬁltrate reduced cortical infract volume signiﬁcantly
(Group 9 in Figure 2). This result suggests that glycoprotein
is one of the eﬃcacious substances in the P. linteus culture
ﬁltrate which reduces cortical infarction.
4.Discussion
4.1. Reduction of Infarct Volume Using P. linteus . Focal
ischemia was induced by clipping and coagulation of the
MCA (modiﬁed Tamura model) in the present study. The
results demonstrated that the 20% culture ﬁltrate was
eﬀective to reduce the volume of brain ischemia compared
with control. The ischemic volume reduction was greater in
the cortex which is a region dominated by some collateral
ﬂow, than in the basal ganglia which is dominated by end
arteries. The area of reduced ischemia in the cortex appeared
to be identical to the ischemic penumbra that can be rescued
with residual cerebral blood ﬂow (collateral ﬂow).
The present results demonstrated that treatment with the
20% culture ﬁltrate 30 and 60min before MCA occlusion
eﬀectively reduced the volume of brain ischemia. The
neuroprotectiveeﬀectinbrainischemiawasdose-dependent.
Furthermore, treatment with the culture ﬁltrate 30min after
cerebral ischemic onset also gave prominent reduction of
cortical infarct volume. From the clinical points of view,
these results suggest a possibility that P. linteus culture
ﬁltrate is very promising in providing wide therapeutic time
windows for the treatment of cerebral ischemia.
Although the present animal experiments showed that
P. linteus, which is a natural spontaneous mushroom,
signiﬁcantly reduced cerebral ischemia in rats, the exact
substances exhibiting neuroprotective eﬀects have not been
identiﬁed. As a preliminary screening for the pharmacolog-
ical active substances in the culture ﬁltrate, we fractionated
the ﬁltrate based on molecular weight. According to the
present results, the fraction with higher MW may contain a
greater proportion of active ingredients responsible for the
reduction of cortical infarct volume. Moreover, the present
results also suggest that glycoprotein had a signiﬁcant eﬀect
in the reduction of cerebral infarct volume.
4.2. Mechanisms of NeuroprotectiveEﬀectsof P.linteus . Based
on the known medicinal action of P. linteus, antioxidant
eﬀect may be involved in the mechanism of neuroprotective
eﬀect in the ischemic brain. In a study that estimated
the superoxide radical erasing eﬀect of a culture of P.
linteus by measuring superoxide radicals trapped with 5,5-
dymethyl-1-pyrroline N-oxide (DMPO) by ESR spectra,
a high superoxide radical erasing eﬀect, that is to say,
antioxidant eﬀect, was recognized in the extract of P. linteus
[7]. Additionally, fractionation studies were attempted to
search for the constituents in fractions that exhibited intense
superoxide radical scavenging activity. Caﬀeic acid was
puriﬁedfromthecomponentwithintense superoxideradical
scavenging activity, which was twice as strong as that of
vitamin C, known to be a potent antioxidant [7]. Moreover,
the component that did not contain caﬀeic acid exhibited
stronger antioxidant activity. Although there seemed to be
other active ingredients with stronger antioxidant action
than caﬀeic acid, it was impossible to isolate the other
active ingredients because they were unstable and possibly
copolymerized during the procedure of isolation.
Caﬀeicacid is the only active ingredient with antioxidant
eﬀect which was puriﬁed from the culture of P. linteus
[7]. Also in a study that compared the hydroxyl radical
scavenging eﬀect of the mycelial extracts of twelve fungi,
the extract of P. linteus had the strongest scavenging eﬀect
[7].
The catechol moiety, which is found in both caﬀeic acid
and tea catechins, has the ability to provide electron to
active oxygen and scavenger active oxygen. Previous studies
have shown that compounds containing the catechol moitey
exhibit signiﬁcant hydroxyl radical scavenging eﬀect, while
other compounds have no such eﬀect [19, 20]. In P. linteus
culture, the antioxidant eﬀect is attributed not only to caﬀeic
acid that contains catechol moiety, but also to other unstable
active ingredients yet to be isolated and identiﬁed.
Caﬀeic acid with MW of 180 is contained in the lower
MW fraction when the culture ﬁltrate of P. linteus is
divided into two fractions at a MW cutoﬀ of 12000. In
the present study, the higher MW fraction showed more
eﬀective reduction of ischemic area than the lower MW
fraction. This result suggests that other ingredients having
stronger antioxidant or other beneﬁcial eﬀects on cerebral
ischemia than caﬀeic acid are present in the higher MW
fraction. Previous reports on the antioxidant eﬀect of P.
linteus indicatednostrong antioxidanteﬀectinthe highMW
fractions [7,21,22].Takingtheseresultstogether,thepresent
study indicates the possibility that cerebral infarct reduction
depends on mechanisms other than the antioxidative eﬀect.
In summary, we hypothesize that the antioxidant eﬀect of
caﬀeic acid in the low MW fraction together with other yet
unidentiﬁed biologically active substances in the high MW
fraction are responsible for the neuroprotective eﬀect of P.
linteus culture ﬁltrate in cerebral ischemia.6 Evidence-Based Complementary and Alternative Medicine
Previous reports on the antioxidant eﬀect of P. linteus
were in vitro studies. On the other hand, the present study
was an in vivo study using MCA occlusion rat models. It
is possible that the high MW ingredients of P. linteus exert
certain eﬀects on the immune system in vivo and manifest
their potential antioxidant eﬀect. While the antioxidant
activity of P. linteus has been reported to be due to caﬀeic
acid which is contained in the lower MW fraction, the anti-
inﬂammatory, anti-allergic and anti-tumor activities of P.
linteus have been reported to be due to proteoglycans which
is included in the higher MW fraction [7, 23, 24]. Nakamura
et al. [7] reported that the main ingredient responsible for
the strongest anti-tumor activity was proteoglycan, and they
isolatedα-1,3-glucan from thecomponentwith thestrongest
antitumoractivity.Kimetal.[24]reportedthatapolysaccha-
ride protein isolated from P. linteus stimulates tumoricidal
cells such as macrophages and NK cells and induced the
proliferation of B cells, which is the main mechanism of the
antitumor activity of P. linteus. Moreover, Song et al. [25]
reported that the antiangiogenic and antioxidant eﬀects of
P. linteus are partially responsible for its antitumor eﬀect.
The reduction of infarct volume induced by P. linteus culture
extract is in part due to some ingredients present in the
higher MW fraction. These ingredients may stimulate the
immune system in vivo, and induce antioxidant eﬀect to
scavenge free radicals in the body. Furthermore, the present
results also suggested that glycoprotein may play important
and major roles in cortical infarct volume reduction induced
by P. linteus. Furtherexperimentsare requiredtoclarifythese
mechanisms.
5.Conclusions
In the present study, treatment with P. linteus culture
ﬁltrate resulted in signiﬁcant reduction of cortical cerebral
infarction in a rat permanent focal ischemia model and the
eﬀect was observed even by post-ischemic treatment. From
the clinical point of view, these results suggest that P. linteus
may be a promising new treatment approach for cerebral
infarction with wide therapeutic time windows. Our ﬁnding
that the higher MW fraction of the P. linteus culture ﬁltrate
demonstrated more prominent eﬀect may provide a clue to
identify the neuroprotective substances and mechanisms.
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